{"doi":"10.1093/infdis/jiae430","title":"CDC-Funded HIV Testing Services Outcomes in <i>Ending the HIV Epidemic in the U.S.</i> (EHE) and Non-EHE Jurisdictions, 2021","abstract":"BACKGROUND: \"Ending the HIV Epidemic in the US\" (EHE) focuses on 57 jurisdictions most affected by HIV. METHODS: Using 2021 data from the National HIV Prevention Program Monitoring and Evaluation system, we calculated distributions of Centers for Disease Control and Prevention-funded HIV tests and HIV testing services outcomes in EHE and non-EHE jurisdictions. We conducted χ2 tests and robust Poisson regression to compare differences in outcomes. RESULTS: Of the 1 753 873 tests, a greater proportion was conducted in EHE (65.7%) vs non-EHE (34.3%) jurisdictions (P < .001). A greater number of persons newly diagnosed were in EHE (n = 5861) vs non-EHE (n = 2329) jurisdictions; newly diagnosed positivity was also higher in EHE (0.5%) vs non-EHE (0.4%) jurisdictions (prevalence ratio [PR], 1.31; 95% CI, 1.25-1.38). Among persons newly diagnosed, there were no differences in linkage to care within 30 days in EHE (77.9%) vs non-EHE (77.1%) jurisdictions (PR, 1.01; 95% CI, .95-1.07). The proportion of persons newly diagnosed interviewed for partner services was lower in EHE (69.0%) vs non-EHE (84.8%) jurisdictions (PR, 0.81; 95% CI, .76-.87). CONCLUSIONS: Centers for Disease Control and Prevention-funded HIV testing services in EHE jurisdictions conducted more HIV testing and diagnosed more persons. Jurisdictions can further expand HIV testing and related services to continue striving toward EHE goals.","journal":"The Journal of Infectious Diseases","year":2024,"id":462216,"datarank":0.16479184330021646,"base_score":1.0986122886681096,"endowment":1.0986122886681096,"self_citation_contribution":0.16479184330021646,"citation_network_contribution":0.0,"self_endowment_contribution":0.16479184330021646,"citer_contribution":0.0,"corpus_percentile":29.844511487584125,"corpus_rank":8690,"citation_count":2,"citer_count":2,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":true,"is_dataset_confidence":0.7005,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":537629,"name":"Mesfin S. Mulatu","orcid":"0000-0002-1643-3340","position":1,"is_corresponding":false},{"id":537630,"name":"Guoshen Wang","orcid":"0000-0002-8420-6465","position":2,"is_corresponding":false},{"id":939708,"name":"Alicia May","orcid":null,"position":3,"is_corresponding":false},{"id":374036,"name":"Andrea R. Moore","orcid":"0000-0002-1236-1554","position":4,"is_corresponding":false},{"id":538170,"name":"Shubha Rao","orcid":null,"position":5,"is_corresponding":false},{"id":544067,"name":"Deesha Patel","orcid":"0000-0003-3080-0642","position":0,"is_corresponding":true}],"reference_count":12,"raw_metadata":null,"created_at":"2026-07-19T02:04:20.631898Z","pmid":"39191533","pmcid":"PMC11794019","fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}